Active — Not RecruitingNot Applicable

Rehabilitation With an Obturator in Maxillary Defects

Egypt60 participantsStarted 2024-02-04

Plain-language summary

During the COVID-19 pandemic, there was a lot of reporting of COVID-19-associated mucormycosis cases. Managing this condition posed a new challenge to clinicians. Management includes therapeutic drugs and aggressive surgical debridement. Due to the unpredictability of disease prognosis and the possible recurrence of the disease, rehabilitation with delayed surgical obturators is beneficial for patients. Hence, the current study aimed to evaluate the impact of delayed surgical obturators on quality of life of COVID-19-associated mucormycosis patients post-maxillectomies

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \*Patients who underwent partial, subtotal and hemi-maxillectomy due to COVID-19-associated mucormycosis and who needed the prosthetic rehabilitation with delayed surgical obturator. Exclusion Criteria: * Patients who are unwilling for the study. * Patients who underwent which bilateral maxillectomies. * Patients having extensive palatal mucosal loss.

What they're measuring

Oral healthy related quality of life (oral health impact profile-49)) (OHIP-49)

Timeframe: 6 months

Trial details

NCT IDNCT06515743

SponsorMenoufia University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-20

View on ClinicalTrials.gov More Mucormycosis trials